Molecular Advances in Male Infertility and Fertility: Importance of Redox Regulation and Oxidative Stress

Oxidative stress causes at least one-third of male infertility, and sperm generate the damaging reactive oxygen species themselves

Journal: International Journal of Molecular Sciences | Published: 2026-04-25 | Type: Narrative Review | PMID: 42123404 Authors: Aitken RJ (University of Newcastle, Australia — one of the field's founding researchers on ROS and sperm biology), Vazquez-Levin MH (IBYME, Argentina), Hallak JS, Teixeira TA, Hallak J (Instituto ANDROSCIENCE, Brazil) Funding/COI: Not disclosed; two authors affiliated with Instituto ANDROSCIENCE, a private male health and fertility center — commercial context not addressed

Summary

Robert Aitken — the researcher who did much of the foundational work establishing oxidative stress as a driver of male infertility — synthesizes current understanding of how reactive oxygen species (ROS) both enable and damage sperm. The central paradox: sperm depend on ROS to capacitate and fertilize eggs, yet overproduction of the same molecules destroys them. The review names three specific ROS sources in sperm (mitochondria, the enzyme IL4I1, and NADPH oxidase NOX5), and argues that antioxidant therapy, while theoretically grounded, lacks the clinical evidence needed to translate into practice.

Claims

• Oxidative stress affects at least one-third of patients attending infertility clinics
• Sperm are unusually vulnerable: their compact, stripped-down architecture leaves minimal antioxidant defenses and almost no capacity for biochemical repair
• Three identified ROS sources in sperm: mitochondria, L-amino acid oxidase (IL4I1), and calcium-dependent NADPH oxidase (NOX5)
• ROS are required for sperm capacitation — they stimulate cAMP and prostaglandin generation, inhibit protein phosphatases, and drive cholesterol removal from the plasma membrane
• During fertilization, ROS activate metalloproteinases that enable zona pellucida penetration and sperm-oocyte fusion
• Antioxidant therapy is flagged as potentially useful but currently under-optimized in composition, dose, and patient selection

Study Quality

This is a narrative review — no formal search methodology, inclusion/exclusion criteria, or PRISMA-style protocol is described. Paper selection reflects expert judgment, not a reproducible process. That cuts both ways: Aitken has contributed decades of primary research in exactly this area, so the synthesis is authoritative; but readers cannot verify what was excluded or why. The "at least one-third" prevalence figure for oxidative stress in infertility clinic patients is stated in the abstract without a pinned citation, which warrants checking against the full text. Mechanistic claims draw on cell biology the authors helped establish — this is expert synthesis, not a disinterested survey.

Red Flags

• Narrative review format: no systematic search, susceptible to selection bias and framing by authors with strong prior positions
• Funding not disclosed; COI not disclosed despite two authors based at Instituto ANDROSCIENCE, a private fertility center where antioxidant products are commercially relevant
• The "at least one-third" prevalence claim carries no explicit citation in the abstract
• "Antioxidants have assumed some importance as a possible therapy" is stated without effect sizes or citation to specific trial data — vague for a clinical claim
• Animal studies folded in alongside human data without clear delineation of what translates

Strengths

• Aitken is among the most cited researchers in reproductive biology; this is primary expertise, not a generalist literature roundup
• Mechanistic specificity is high: identifying IL4I1 and NOX5 as discrete ROS sources goes well beyond the standard "mitochondria generate free radicals" summary
• Honestly frames the ROS paradox rather than treating oxidative damage as purely pathological — acknowledges why sperm generate ROS at all
• Calls out the gap between antioxidant therapy's theoretical rationale and its clinical evidence base, and asks for better diagnostics before treatment — rare restraint for a paper that could easily oversell

Verdict

If you work in male infertility or reproductive biology, Aitken's reviews are the field's running intellectual backbone and this one earns its place. For a general evidence consumer, the missing COI disclosure from an author group affiliated with a private fertility clinic is a yellow flag, and the narrative format means you're getting expert synthesis rather than systematic evidence. The core mechanistic picture — sperm as partly their own worst enemy, ROS as simultaneously required signal and potential toxin — is well-established science. What the paper concedes it cannot deliver, and what the field still lacks, is clinical-grade evidence on how to actually fix oxidative stress in infertile men.